Jonathan D. Bender MD, MS , Natasha Pillay-Smiley DO , Garick D. Hill MD, MS , Peter de Blank MD, MSCE , Trent R. Hummel MD , Brian D. Weiss MD , Ashish Kumar MD, PhD , Huaiyu Zang PhD , Nicholas J. Ollberding PhD , Thomas D. Ryan MD, PhD
{"title":"Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors","authors":"Jonathan D. Bender MD, MS , Natasha Pillay-Smiley DO , Garick D. Hill MD, MS , Peter de Blank MD, MSCE , Trent R. Hummel MD , Brian D. Weiss MD , Ashish Kumar MD, PhD , Huaiyu Zang PhD , Nicholas J. Ollberding PhD , Thomas D. Ryan MD, PhD","doi":"10.1016/j.jaccao.2024.07.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"6 5","pages":"Pages 794-796"},"PeriodicalIF":12.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jacc: Cardiooncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666087324002230","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍：
JACC: CardioOncology is a specialized journal that belongs to the esteemed Journal of the American College of Cardiology (JACC) family. Its purpose is to enhance cardiovascular care for cancer patients by publishing high-quality, innovative scientific research and sharing evidence-based knowledge.
The journal aims to revolutionize the field of cardio-oncology and actively involve and educate professionals in both cardiovascular and oncology fields. It covers a wide range of topics including pre-clinical, translational, and clinical research, as well as best practices in cardio-oncology. Key areas of focus include understanding disease mechanisms, utilizing in vitro and in vivo models, exploring novel and traditional therapeutics (across Phase I-IV trials), studying epidemiology, employing precision medicine, and investigating primary and secondary prevention.
Amyloidosis, cardiovascular risk factors, heart failure, and vascular disease are some examples of the disease states that are of particular interest to the journal. However, it welcomes research on other relevant conditions as well.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
